Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek! Voor het nieuwsoverzicht (nieuwsfeed) op deze pagina worden van een aantal organisaties, instanties, bedrijven en personen de RSS feeds gevolgd. De RSS feeds worden elke 5 – 10 minuten ververst en op deze pagina weergegeven. Voor een overzicht van alle nieuwsbronnen, klik hier.
Omdat de plug-in die ik voor deze pagina gebruik niet overweg kan met de RSS feeds van een aantal organisaties, instanties, bedrijven en personen heb ik een alternatieve pagina ingericht om de RSS feeds van deze organisaties, instanties, bedrijven en personen toch weer te kunnen geven. Klik hier om het alternatieve nieuwsoverzicht te raadplegen.
Meer nieuws en actualiteiten:
- Alternatief nieuwsoverzicht
- Archief Nieuwsbrief voor Goede Onderzoekspraktijken
- Uitgelicht & Gespot op internet
Nieuwsfeed
- FDA Adverse Event Reporting System (FAERS) Public Dashboard
- FDA's Adverse Event Reporting System (FAERS)
- Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data Sets
- New Paper Makes the Case for AI-Specific Guidance in Research Oversight
- PAPZIMEOS
- Preprint server removes study attributing increased infant mortality to vaccines
- Tissue and Tissue Product Questions and Answers
- Common Ingredients in FDA-Approved Vaccines
- Biological Product Deviations
- Vaccine Safety Questions and Answers
- ACT EU roadmap of clinical trial methodology guidance
- Zostavax (Herpes Zoster Vaccine) Questions and Answers
- Emergency Use Authorization for Vaccines Explained
- Bioresearch Monitoring Information System (BMIS)
- Premarket Notification 510(k) Process for CBER-Regulated Products
- Influenza Virus Vaccine Safety & Availability
- Draft concept paper on the development of a reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products
- [133] Heterofriendly: The Intuition for Why You Always Need Robust Standard Errors
- What triggers the recent Changes in EU GMP?
- Why Supplier Qualification is more than just an Audit
- Warning Letter to US Contract Manufacturer of OTC Drugs due to Cross-Contamination Risk
- Warning Letter following Complaints about Tablets
- What does the FDA expect regarding Facility Maintenance?
- Revised USP Chapter Plastic Packaging Systems and Their Materials of Construction
- The RW Daily: "Researcher ‘honestly shocked’ to discover name on paper. And "How China’s universities joined the global elite."
- CMDh: Update of Q&As for Generic Drug Submissions
- ICTD 2026: Register now! 📍
- Nasal vaccine protects mice from various respiratory infections
- Decoding the genetics of several cancers in cats
- Update on the German CBD Monograph
- Evidence-based Classification Reviews (EBRs) on Herbal Medicines
- UK baby born after mother’s womb transplant
- Itching mice help manage skin conditions
- Untitled Letters
- Weekend reads: Institute to stop paying fees for some OA journals; sleuths’ tips for spotting fraud; Bayer sues J&J over ‘false and misleading claims’
- Weekend reads: Institute to stop paying fees for some OA journals; sleuths’ tips for spotting fraud; Bayer sues J&J over ‘false and misleading claims’
- Machine learning to optimize precision in the analysis of randomized trials: A journey in pre-specified, yet data-adaptive learning
- Pick The Right PV Technology With Help From A Safety Data Management Expert
- Novel Drug Approvals for 2026
- Researcher ‘honestly shocked’ to discover name on paper, editor claims misunderstanding
- What’s New for Biologics
- What's New Related to Drugs
- Drug Trials Snapshot: HYRNUO
- Certification Process for Designated Medical Gases
- Accelerated Approval Program
- Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers - 04/15/2026
- Registered Outsourcing Facilities
- CEPI 3.0: Securing the future against epidemic and pandemic threats
- Equitable Care, Accelerated Timelines: Expanding Global Access to Rare Disease Research
- The RW Daily: An EIC cited in more than half his journal's papers. And: Announcing the Retraction Watch Research Accountability Reporting Fellowship
